Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
03 Février 2025 - 10:57PM
Edgar (US Regulatory)
NYC#: 139632.2
Exhibit A
Joint Filing Agreement
The undersigned hereby agree that this Statement on Schedule 13G/A with respect to the beneficial ownership of shares of Common Stock of Cellectar Biosciences, Inc. is filed jointly, on behalf of each of them.
Rosalind Advisors, Inc.
By: _____________________________
Name: Steven Salamon
Title: President
Rosalind Master Fund L.P.
By: _____________________________
Name: Mike McDonald
Title: Director, Rosalind (Cayman) Ltd. (as General Partner to Rosalind Master Fund)
By: _____________________________
Name: Steven Salamon
Rosalind Opportunities Fund I L.P.
By: _____________________________
Name: Steven Salamon
Title: Director, Rosalind Opportunities Fund I GP. Inc. (as General Partners to Rosalind Opportunities Fund I)
NYC#: 139632.2
Cellectar Biosciences (NASDAQ:CLRB)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025
Cellectar Biosciences (NASDAQ:CLRB)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025